ActivistsInvestorsTrumpPoliticiansSerenityCitriniSemianalysisTradeArbitrageSearch
By filer · By stock

$GKOS:NYSE · GLAUKOS CORP

Glaukos is an ophthalmic medical technology company that develops micro-invasive devices and drug-delivery therapies for treating glaucoma, corneal disorders, and retinal diseases.

2 tracked filer(s) hold this · 1 opened, 0 added, 0 trimmed in 30-SEP-2025

Aggregate 13FScore 38 — mean of 1 scored holder(s). Higher = the smart money in this name has the better track record.

Filer13FScoreThis quarterSharesValue% of their book
Steve Cohen / Point72—New buy24,728$2,016,5770.1%
Ancora38Holds (flat)17$1,3860.0%

Beyond 13F — activists, insiders, politicians & research

Trump & executive branch trades all Trump/exec trades →

4 disclosed trade(s) by 1 filer(s).

Trade dateWhoTypeAmount
2026-07-01Trump, Donald J PresidentSELL$15,001 - $50,000PTR
2026-05-14Trump, Donald J PresidentSELL$1,001-$15,000PTR
2026-05-14Trump, Donald J PresidentBUY$15,001 - $50,000PTR
2026-05-14Trump, Donald J PresidentBUY$15,001 - $50,000PTR

Every tracked holder of this name, sorted new → added → flat → trimmed. Shares = reported 13F share count; Value as reported (a few managers file values in $thousands). Generated 2026-07-02.